References
- Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 1991;17:758-69. https://doi.org/10.1016/S0735-1097(10)80196-2
- Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369-75. https://doi.org/10.1016/S0735-1097(85)80174-1
- Bae Y, Jeong MH, Jang YS, et al. Comparison of porcine coronary stent restenosis between MAC (Maximum Arterial Re-Creation) stent and Palmaz-Schatz stent. Korean Circ J 1998;28:89-96. https://doi.org/10.4070/kcj.1998.28.1.89
- Giraldo AA, Esposo OM, Meis JM. Intimal hyperplasia as a cause of restenosis after percutaneous transluminal coronary angioplasty. Arch Pathol Lab Med 1985;109:173-5.
- Ahn YK, Jeong MH, Kim JW, et al. Preventive effects of the heparincoated stent on restenosis in the porcine model. Catheter Cardiovasc Interv 1999;48:324-30. https://doi.org/10.1002/(SICI)1522-726X(199911)48:3<324::AID-CCD20>3.0.CO;2-K
- Hong YJ, Jeong MH, Lim SY, et al. Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting. Circ J 2005;69:1477-83. https://doi.org/10.1253/circj.69.1477
- Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. Instent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-30.
- Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-63. https://doi.org/10.1016/S0735-1097(99)00486-6
- Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52. https://doi.org/10.1161/01.CIR.99.1.44
- Pratt RE, Dzau VJ. Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system. Circulation 1996;93:848-52. https://doi.org/10.1161/01.CIR.93.5.848
- Nakamura M, Funakoshi T, Arakawa N, Yoshida H, Makita S, Hiramori K. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure. J Am Coll Cardiol 1994;24:1321-7. https://doi.org/10.1016/0735-1097(94)90115-5
- Hirooka Y, Imaizumi T, Masaki H, et al. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension 1992;20:175-80. https://doi.org/10.1161/01.HYP.20.2.175
- Mancini GB, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation 1996;94:258-65. https://doi.org/10.1161/01.CIR.94.3.258
- Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992;19:267-74. https://doi.org/10.1016/0735-1097(92)90476-4
- Kolodgie FD, John M, Khurana C, et al. Sustained reduction of instent neointimal growth with the use of a novel systemic nanoparticle paclitaxel. Circulation 2002;106:1195-8. https://doi.org/10.1161/01.CIR.0000032141.31476.15
- Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52. https://doi.org/10.1161/01.CIR.99.1.44
- Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus-or paclitaxel-eluting stents. Circulation 2005;112:270-8. https://doi.org/10.1161/CIRCULATIONAHA.104.508937
- Carter AJ, Aggarwal M, Kopia GA, et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004;63:617-24. https://doi.org/10.1016/j.cardiores.2004.04.029
- Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001;104:473-9. https://doi.org/10.1161/hc3001.092037
- Ribichini F, Steffenino G, Dellavalle A, et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation 1998;97:147-54. https://doi.org/10.1161/01.CIR.97.2.147
- Ribichini F, Vado A, Uslenghi E, Matullo G, Piazza A. Relationship between plasma ACE activity and the proliferative healing process in coronary vessel injury after coronary stenting. Atherosclerosis 2000;152:261-3. https://doi.org/10.1016/S0021-9150(00)00509-8
- Ohishi M, Ueda M, Rakugi H, et al. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation 1997;96:3328-37. https://doi.org/10.1161/01.CIR.96.10.3328
- Bell L, Madri JA. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 1990;137:7-12.
- Pratt RE, Dzau VJ. Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system. Circulation 1996;93:848-52. https://doi.org/10.1161/01.CIR.93.5.848
- Campbell-Boswell M, Robertson AL Jr. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 1981;35:265-76. https://doi.org/10.1016/0014-4800(81)90066-6
- Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-6. https://doi.org/10.1161/01.RES.68.2.450
- Scott-Burden T, Hahn AW, Resink TJ, Buhler FR. Modulation of extracellular matrix by angiotensin II: Stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. J Cardiovasc Pharmacol 1990;16(Suppl 4):S36-41.
- Powell JS, Clozel JP, Muller RK, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-8. https://doi.org/10.1126/science.2526370
- Huber KC, Schwartz RS, Edwards WD, et al. Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model. Am Heart J 1993;125:695-701. https://doi.org/10.1016/0002-8703(93)90160-B
Cited by
- Long-term effects of ACE inhibitor on vascular remodelling vol.9, pp.6, 2014, https://doi.org/10.2478/s11536-013-0343-6
- Long-term preclinical evaluation of bioabsorbable polymer-coated drug-eluting stent in a porcine model vol.25, pp.7, 2011, https://doi.org/10.1007/s13233-017-5067-z
- Synthetic E-selectin prevents postoperative vascular restenosis by inhibiting nuclear factor κB in rats vol.17, pp.4, 2011, https://doi.org/10.3892/mmr.2018.8536